IDENTIFICATION OF ANTI-CYTOPLASMIC ANTIBODIES
About This Opportunity
TranslatedThis tender concerns the identification of anti-cytoplasmic antibodies. This is a diagnostic procedure within the medical and laboratory services sector. The objective is to procure services or reagents for the accurate detection and quantification of these specific antibodies. Anti-cytoplasmic antibodies are a group of autoantibodies that target components within the cytoplasm of cells. Their identification is crucial for the diagnosis and management of various autoimmune diseases, particularly those affecting the gastrointestinal tract, liver, and lungs. Examples include inflammatory bowel diseases like ulcerative colitis and Crohn's disease, as well as primary sclerosing cholangitis and certain types of vasculitis. The tender likely requires a reliable and sensitive method for antibody detection, potentially involving techniques such as indirect immunofluorescence (IIF) or enzyme-linked immunosorbent assays (ELISA). Specificity and reproducibility of the results will be paramount. Further details regarding the required volume, frequency of testing, specific antibody targets (e.g., ANCA, ASCA), and desired turnaround times are expected to be outlined in the full tender documentation. This procurement aims to ensure healthcare providers have access to essential diagnostic tools for patient care in autoimmune conditions.
This is a supplies contract in the health and medical services, Research and trade and industry sectors, with a focus on Medical Equipment, Laboratory, Laboratories and R&D equipment. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 9,280.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThis tender, titled "IDENTIFICAÇÃO AC ANTICITOPLASMÁTICOS," is being issued through Portugal's public procurement portal, BASE (base.gov.pt). The contracting authority seeks to procure services or products related to the identification of anti-cytoplasmic antibodies. This type of procurement typically involves the acquisition of diagnostic reagents, laboratory equipment, or related testing services essential for medical diagnostics and research.
The scope of this tender is expected to encompass the supply of high-quality materials or the provision of specialized analytical services that enable the accurate detection and quantification of anti-cytoplasmic antibodies. Such antibodies are often indicators of various autoimmune diseases, making their reliable identification crucial for patient diagnosis and management.
Interested suppliers are anticipated to demonstrate their capability to provide products or services that meet stringent international quality standards, including relevant certifications and proven efficacy.
Potential bidders should be prepared to submit detailed technical specifications, evidence of past performance in similar procurements, and competitive pricing proposals. The tender process will likely involve a thorough evaluation of both technical merit and commercial viability. Further details regarding specific technical requirements, evaluation criteria, and submission deadlines will be made available through the BASE portal.
This procurement represents an opportunity for qualified entities to engage with the Portuguese public health sector.
Data provenance
This notice is sourced from base_gov_pt and was originally published on March 5, 2026. Last refreshed 4 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde de Viseu Dão-Lafões, EPE
Unidade Local de Saúde de Viseu Dão-Lafões, EPE has issued 600 procurement notices on BidsFactory, including 12 currently open and 543 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Information & Communication Technology. All notices are published for Portugal. Notices are distributed via base_gov_pt and TED - Tenders Electronic Daily (EU). Most recent publication: June 18, 2026.
Frequently asked questions about this tender
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to EUROIMMUN Portugal. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde de Viseu Dão-Lafões, EPE in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €9,280. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.
Sectors & Categories
Key Details
Contracting Authority
Companies That Won Similar
Companies with awards in Health & Medical in Portugal